Aidoc: Bringing AI to the heart of patient care

When we first invested in Elad, Michael and Guy, back in 2019, their mission was simple and audacious: harness AI to save lives. 

Six years on, and Aidoc’s clinical‑AI platform now helps physicians care for over 45 million patients annually across hundreds of hospitals worldwide. 

It’s why we’re thrilled to co‑lead Aidoc’s new  $150 million round alongside General Catalyst - our fifth investment in the company since 2019.

A massive moment for clinical AI

 ⁠Healthcare is increasingly under pressure - physician shortages are widening across the board, and clinical knowledge is expanding at a rate that exceeds the capacity of any individual to absorb.

Imaging highlights the strain: scan volumes continue to climb while radiologist numbers remain flat, resulting in heavier workloads, longer wait times, and, ultimately, missed findings.

Enter clinical AI - always‑on algorithms that flag high‑risk findings, prioritise urgent cases and automate follow‑ups, helping physicians make faster, more confident decisions. 

Use of this technology has now become the ‘default’ for hospital groups, delivering higher standards of patient care and supporting the ever-increasing physician workload.

As new AI techniques evolve, Aidoc has been world-leading in its ability to learn, build, and launch new products for physicians, while maintaining the accuracy for which it is well-known. ⁠

Mission-driven team and culture

Aidoc blends cutting‑edge R&D with clinician empathy, with a culture that emphasises ownership, collaboration and a relentless focus on outcomes. 

From day one, the team has worked closely with clinicians to build great products, focusing on what matters: high levels of accuracy and a zero-friction workflow. This approach has built strong trust with clinicians and formed habits around the product.

The result is clear: long-standing partnerships with health-system leaders, such as Mount Sinai, Mayo Clinic, Northwell, and Yale, and on track to support 100 million patients annually within three years.⁠

⁠Why we’re all in - again!

Aidoc has the ingredients we look for in a generational company that gets better as it gets bigger:

1. Category leadership, with an incredibly extensive portfolio of FDA‑cleared products.

2. Compounding data scale continually sharpens model accuracy.

3. Clear economic value & product love - better outcomes, lower costs, reduced burnout for health systems and professionals.

We strongly believe AI‑augmented care will become the standard of care across healthcare, and with fresh capital and a powerful new foundation model, Aidoc is accelerating that future—one lifesaving algorithm at a time.

We’re honoured to be a small part of the journey alongside Elad, Michael, Guy and the entire Aidoc team, and to invest for a fifth time as they bring AI to the heart of patient care.